Acute Hemodynamic Response to Carvedilol in Predicting Survival in Acute on Chronic Liver Failure Patients - A Pilot Study.
NCT05180292
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Acute on Chronic Liver Failure
Interventions
DRUG:
Carvedilol 12.5 MG
Sponsor
Institute of Liver and Biliary Sciences, India